Please assess the completion status of the following clinical trial:

Trial Title: Perioperative Analgesic Modalities for Breast Cancer Surgeries

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* female 18-65 years old patients undergoing modified radical mastectomy~Exclusion Criteria:~* patient refusal, local infection at site of block coagulation defect abnormal kidney or liver functions

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- erector spinae block (Type: EXPERIMENTAL): Ultrasound guided erector spinae block with will be done after induction of intravenous anesthesia. After identification of trapezius, rhomboid major, and erector spinae muscles. The needle will be inserted in a cephalad-to-caudal direction until the tip contact transverse process and the needle tip is visualized in the plane deep to the erector spinae muscle. The needle tip position is confirmed by visualizing linear spread of test dose between the muscles after injection. A total dose of 25 mL of 0.25% bupivacaine will be injected.
- serratus anterior block (Type: EXPERIMENTAL): Ultrasound guided serratus anterior block will be done after induction of intravenous anesthesia. The serratus anterior, latissimus dorsi, and the intercostal muscles will be identified in the fourth and fifth intercostal level, an 18 G Tuohy needle will be advanced in the plane between the serratus anterior muscle and the intercostal muscles. A total dose of bupivacaine 25ml in a concentration of 0.25% will be administered under the serratus muscle after a test dose using an in-plane technique.
- intravenous morphine (Type: ACTIVE_COMPARATOR): intravenous morphine will be administrated in a dose of 0.1 mg per kg after induction of general anesthesia

Based on this trial design, predict the completion outcome and termination type (if applicable).